Detection of Anti-SSA Antibodies by Indirect Immunofluorescence

Clinical Chemistry - Tập 50 Số 12 - Trang 2361-2369 - 2004
Xavier Bossuyt1, Johan Frans1, Ann Hendrickx1, G Godefridis1, René Westhovens2, Godelieve Mariën1
1*Laboratory Medicine and
2Internal Medicine, University Hospital Leuven, Leuven, Belgium

Tóm tắt

AbstractBackground: HEp-2 cells that overexpress the human 60-kDa SSA antigen have been used to improve sensitivity and specificity for the detection of anti-SSA antibodies by indirect immunofluorescence. We describe a survey on the detection of anti-SSA antibodies using a commercial substrate that overexpresses SSA.Methods: The evaluation was done on 18 371 consecutive samples submitted to the laboratory for detection of anti-nuclear antibodies, from which 188 anti-SSA antibody-containing and clinically documented samples were obtained. The presence of anti-SSA antibodies produced a distinct bright speckled pattern with nucleolar staining in 10–20% of interphase cells. The identity of all anti-SSA antibodies was confirmed by dot-blot analysis.Results:Samples containing anti-SSA antibodies were separated into three main groups: group I, distinctive SSA pattern and other nuclear staining (50%); group II, only the distinctive SSA pattern (29%); group III, nuclear staining but without the distinctive SSA pattern (21%). Anti-SSA antibodies with concurrent SSB antibodies were associated with group I, whereas anti-SSA antibodies with concurrent U1-RNP antibodies were associated with group III. Group I included mainly patients with Sjögren syndrome and systemic lupus erythematosus (SLE), whereas group III included patients with mixed connective tissue disease and SLE. Diseases not classically associated with the presence of anti-SSA antibodies were found in group II in >50% of the cases.Conclusions: SSA-positive individuals were identified in a population selected on the basis of HEp-2000 positivity. Our study highlights diseases associated with anti-SSA antibodies and associations between the presence of the distinctive SSA pattern on HEp-2000 and some clinical conditions.

Từ khóa


Tài liệu tham khảo

1992, Rheum Dis Clin North Am, 18, 551, 10.1016/S0889-857X(21)00316-1

2002, Autoantigens, autoantibodies, autoimmunity, Vol. 2, 166

1983, J Am Acad Dermatol, 8, 611, 10.1016/S0190-9622(83)70065-4

1984, Arthritis Rheum, 27, 166, 10.1002/art.1780270207

1996, Autoantibodies, 74

2000, Arch Pathol Lab Med, 124, 71, 10.5858/2000-124-0071-GFCUOT

1999, J Clin Pathol, 52, 684, 10.1136/jcp.52.9.684

2000, Clin Rheum, 19, 291, 10.1007/s100670070048

2000, Ann Clin Biochem, 37, 216, 10.1258/0004563001899032

2002, J Clin Lab Anal, 16, 103, 10.1002/jcla.10026

2000, Clin Chem, 48, 2171

1999, Clin Chem, 45, 311

1996, Ann Rheum Dis, 5, 116

1997, Arthritis Rheum, 40, 1725

1987, Mixed connective tissue disease and antinuclear antibodies, 33

2003, Clin Chem, 49, 7, 10.1373/49.1.7

1999, Arthritis Rheum, 42, 199, 10.1002/1529-0131(199902)42:2<199::AID-ANR1>3.0.CO;2-1

Thông tin
Thông tin xuất bản

Clinical Chemistry

Tập 50 Số 12

2361-2369

Thông tin tác giả